GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Kanghua Biological Products Co Ltd (SZSE:300841) » Definitions » 3-Year Revenue Growth Rate

Chengdu Kanghua Biological Products Co (SZSE:300841) 3-Year Revenue Growth Rate : 4.20% (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Chengdu Kanghua Biological Products Co 3-Year Revenue Growth Rate?

Chengdu Kanghua Biological Products Co's Revenue per Share for the three months ended in Mar. 2025 was ¥1.06.

During the past 12 months, Chengdu Kanghua Biological Products Co's average Revenue per Share Growth Rate was -20.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 10 years, the highest 3-Year average Revenue per Share Growth Rate of Chengdu Kanghua Biological Products Co was 25.40% per year. The lowest was 4.20% per year. And the median was 15.05% per year.


Competitive Comparison of Chengdu Kanghua Biological Products Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Chengdu Kanghua Biological Products Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Kanghua Biological Products Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Kanghua Biological Products Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Chengdu Kanghua Biological Products Co's 3-Year Revenue Growth Rate falls into.


;
;

Chengdu Kanghua Biological Products Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Chengdu Kanghua Biological Products Co  (SZSE:300841) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Chengdu Kanghua Biological Products Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Chengdu Kanghua Biological Products Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Kanghua Biological Products Co Business Description

Traded in Other Exchanges
N/A
Address
No. 182, Beijing Road, Chengdu Economic and Technological Development Zone, Sichuan Province, Chengdu, CHN, 610100
Chengdu Kanghua Biological Products Co Ltd is engaged in research, development, production, sales and technical services of biological products for prevention, and the existing products include Group ACYW135 Meningococcal Polysaccharide Vaccine-Maikexin, Rabies Vaccine (human diploid cell) for Human Use, freeze-dried - HDCV. The company's products include ACYW135 Meningococcal Polysaccharide Vaccine; and Rabies Vaccine.
Executives
Sun Wan Feng Executives
Hou Wen Li Directors, executives
Wu Wen Nian Executives
Chen Huai Gong Executives
Li Sheng You Executives
Wang Qing Han Directors, executives
Li Xiao Wen Supervisors

Chengdu Kanghua Biological Products Co Headlines

No Headlines